Decellularized Tissue Composite Biomembrane for Suturable Anti-Adhesion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing anti-adhesion materials and biomembranes are inadequate in preventing postoperative tissue adhesion, lack sufficient strength for suturing, and exhibit insufficient biocompatibility, leading to inflammation and foreign body reactions.
Innovation Solution
A biocompatible anti-adhesion material is developed using decellularized tissues complexed with polymers such as alginic acid, gelatin, or fibrin glue, which are applied to surgical sites to prevent adhesion and serve as a tissue substitute.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If foreign material such as silicon membrane, polyurethane, or e-PTFE sheet is used for pericardium substitution, then structural support and adhesion prevention are achieved, but inflammation in surrounding tissues and mediastinitis occur due to poor biocompatibility
Solution Approach 1:
The invention extracts and removes cells from biological tissues through decellularization processes (enzymatic treatment with collagenase, dispase, trypsin; chemical treatment with SDS; physical treatment with high hydrostatic pressure), retaining only the extracellular matrix structure. This eliminates immunogenic cellular components while preserving the functional scaffold, thereby preventing inflammation and mediastinitis while maintaining adhesion prevention capabilities
Solution Approach 2:
The invention creates a composite material combining decellularized tissue extracellular matrix with biocompatible polymers (fibrin glue, gelatin, alginic acid). This composite structure integrates the mechanical strength and adhesion prevention of synthetic polymers with the high biocompatibility and regenerative properties of natural extracellular matrix, resolving the contradiction between structural support and inflammatory response
2Reliability
If conventional anti-adhesion materials are used, then adhesion prevention is provided, but sufficient strength for suturing is not achieved
Solution Approach 1:
The invention merges decellularized tissue sheets with biocompatible polymers (fibrin glue, gelatin, alginic acid) to create a composite anti-adhesion material. The polymer network provides tensile strength for suturing while the decellularized extracellular matrix maintains adhesion prevention properties, achieving both requirements simultaneously
Solution Approach 2:
The composite structure combines the mechanical reinforcement of polymer fibers with the functional properties of decellularized tissue. The polymer phase provides structural integrity and suture hold, while the extracellular matrix phase maintains biocompatibility and adhesion resistance, resolving the strength-deficiency problem
3Object-affected harmful factors
If decellularized tissues are used as anti-adhesion material, then biocompatibility and anti-adhesion effect are improved, but material strength may be insufficient without polymer complexation
Solution Approach 1:
The invention forms composite materials where decellularized extracellular matrix is integrated with biocompatible polymers. The polymer component compensates for the inherent weakness of decellularized tissue, providing sufficient mechanical strength while the decellularized matrix maintains high biocompatibility and anti-adhesion functionality
Solution Approach 2:
The invention changes the physical and chemical parameters of decellularized tissue by complexing with polymers under controlled conditions (pH adjustment, ionic crosslinking with Ca2+ for alginic acid, enzymatic crosslinking for fibrin). This enhances mechanical strength parameters while preserving biocompatibility, resolving the strength deficiency
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The material effectively reduces postoperative adhesion, provides sufficient strength for suturing, and enhances biocompatibility, minimizing inflammation and foreign body reactions.
Implementation Method 1
a biocompatible anti-adhesion material is developed using decellularized tissues complexed with polymers such as alginic acid, gelatin, or fibrin glue
Implementation Method 2
decellularized tissues complexed with polymers
Implementation Method 3
The material effectively reduces postoperative adhesion
Implementation Method 4
provides sufficient strength for suturing
Implementation Method 5
enhances biocompatibility, minimizing inflammation and foreign body reactions
Data Source
Figure 1(A)~1(H)
AI summary
An anti-adhesion material comprising decellularized tissues and a biocompatible polymer or fibrin glue; a method for preparing an anti-adhesion material comprising complexing a biocompatible polymer or fibrin glue to decellularized tissues; an anti-adhesion material kit comprising decellularized tissues and a biocompatible polymer or fibrin glue; a substitute biomembrane comprising decellularized tissues and a biocompatible polymer or fibrin glue; a method for preparing a substitute biomembrane comprising complexing a biocompatible polymer or fibrin glue to decellularized tissues; and a substitute biomembrane kit comprising decellularized tissues and a biocompatible polymer or fibrin glue.